Market revenue in 2023 | USD 602.9 million |
Market revenue in 2030 | USD 738.3 million |
Growth rate | 2.9% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.33% in 2023. Horizon Databook has segmented the North America in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
North America is one of the developed regions with high healthcare expenditure and held a substantial share of the global in vitro diagnostics quality control market in 2023. This large share can be attributed to the presence of a well-established healthcare system and clinical diagnostics industry in the U.S.
which has created a significant demand for internal & external quality control solutions for clinical and research purposes. In addition, continuous advancements in the field of IVD and high affordability & adoption of innovative and advanced diagnostic systems & solutions in the region make it an attractive market globally.
The presence of the U.S. FDA and many accredited diagnostic laboratories, coupled with strong quality control regulation systems, is driving market expansion in the region. According to the American Clinical Laboratory Association.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America in vitro diagnostics quality control market , including forecasts for subscribers. This continent databook contains high-level insights into North America in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account